Clinical Trial Update: Olanzapine in Patients With Advanced Cancer and Weight Loss [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating olanzapine in patients with advanced cancer and weight loss has been completed; the update outlines study design and enrollment status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer, Weight Loss | Phase 1 | Status: COMPLETED